Bipolar disorder does not stem from a single broken mechanism. It involves overlapping disruptions across genetics, brain chemistry, neural circuitry, stress hormones, immune signaling, and cellular energy systems. Researchers have spent decades trying to pin down a unifying cause, and the honest picture that has emerged is one of many biological pathways converging on mood instability. Understanding how these pathways interact explains why the disorder is so varied in its presentation and why effective treatment often requires hitting more than one biological target at once.
A Genetic Architecture Built From Many Small Effects
Bipolar disorder runs in families, and twin studies consistently place its heritability among the highest of any psychiatric condition. But the genetics are not simple. Rather than one or two genes driving the disorder, it is shaped by many common genetic variants, each contributing a small amount of risk. Genome-wide association studies have begun to map these variants, revealing a highly polygenic landscape with substantial genetic overlap with other psychiatric conditions like schizophrenia and major depression.1PubMed Central. Polygenic Risk Scores for Bipolar Disorder: Progress and Perspectives
Among the most replicated genetic findings is a variant in a gene called CACNA1C, which codes for a subunit of a voltage-gated calcium channel in neurons.2PubMed Central. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease Calcium channels are fundamental to how neurons fire and communicate with each other, so a genetic variant that subtly alters their function can ripple through multiple brain systems at once. Another gene, ANK3, has been implicated alongside CACNA1C, and together they point to calcium signaling as a central pathway in bipolar vulnerability.3PubMed Central. Molecular neurobiological clues to the pathogenesis of bipolar disorder Variants in CACNA1C have also been linked to measurable differences in brain structure, including changes in cortical thickness, suggesting the gene’s effects extend from the molecular level all the way up to gross brain anatomy.4PubMed Central. CACNA1C polymorphism and brain cortical structure in bipolar disorder
Neurotransmitter Imbalances Go Beyond Serotonin
Public understanding of mood disorders often centers on serotonin, but the neurotransmitter story in bipolar disorder is more complicated and arguably more interesting. Dopamine has long been a primary suspect. A detailed review of imaging and pharmacological evidence suggests that during mania, elevated availability of certain dopamine receptors in a brain region called the striatum leads to increased dopaminergic activity, while during depressive episodes, increased dopamine transporter levels pull dopamine out of the gap between neurons too quickly, dampening the signal. The swing between these two states, a failure of the brain’s usual ability to keep dopamine receptor and transporter levels in balance, may be a core driver of mood cycling.5PubMed Central. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
Glutamate and GABA add another layer. Glutamate is the brain’s main excitatory chemical messenger, and GABA is its main inhibitory one. Brain imaging studies have found elevated glutamate levels in people with bipolar disorder with surprisingly high consistency across research groups.6PubMed Central. Elevated Brain Glutamate Levels in Bipolar Disorder and Pyruvate Carboxylase-Mediated Anaplerosis The balance between glutamate and GABA matters as much as the level of either one alone. Some evidence suggests that mood instability results from an imbalance between excitatory glutamatergic and inhibitory GABAergic activity, though relatively few studies have measured both chemicals simultaneously in the same patients.7PubMed. ACC Glu/GABA ratio is decreased in euthymic bipolar disorder I patients When alcohol dependence is added to the picture, GABA levels in the front of the brain drop further, highlighting how co-occurring conditions can worsen the underlying chemical imbalance.8Translational Psychiatry. Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence
Faulty Wiring Between the Prefrontal Cortex and the Amygdala
If neurotransmitters are the signals, brain circuits are the highways those signals travel on. One circuit that keeps appearing in bipolar research connects the prefrontal cortex, which is involved in planning and impulse control, to the amygdala, which processes emotion and threat. In healthy brains, the prefrontal cortex exerts a kind of top-down regulation over the amygdala, keeping emotional reactions proportionate. In bipolar disorder, this connection is weakened. Neuroimaging research has shown that people with bipolar I disorder have disrupted connectivity between the amygdala and the prefrontal cortex, and that the severity of these disruptions tracks with lifetime psychotic symptom severity.9PubMed Central. Global Prefrontal and Fronto-amygdala Dysconnectivity in Bipolar I Disorder with Psychosis History
The structural wiring itself may be partly to blame. Research combining functional brain scans with imaging of white matter tracts has found that abnormalities in the white matter connecting the ventral prefrontal cortex and amygdala are associated with disrupted coordinated activity between these regions.10PubMed Central. A Ventral Prefrontal-Amygdala Neural System in Bipolar Disorder: A View from Neuroimaging Research This is not just an academic observation. Lithium treatment over eight weeks was associated with increased connectivity between the amygdala and the medial prefrontal cortex, and that increased connectivity correlated with clinical improvement.11PubMed Central. Lithium monotherapy associated clinical improvement effects on amygdala-ventromedial prefrontal cortex resting state connectivity in bipolar disorder In other words, fixing the wiring problem appears to be part of how effective treatment works.
Structural Brain Changes and the Kindling Effect
Bipolar disorder is not static. Over time, the brain can show progressive structural changes, and mood episodes themselves appear to accelerate this process. Manic episodes have been linked to faster decreases in cortical volume and thickness, with the most consistent reductions occurring in prefrontal brain areas.12Molecular Psychiatry. Mania-related effects on structural brain changes in bipolar disorder – a narrative review of the evidence Depressive episodes take a toll too: patients with more than two depressive episodes between assessments showed greater cortical thinning in the temporal lobe compared to those with fewer episodes.13PubMed. Mood episodes are associated with increased cortical thinning
This progressive deterioration has been framed through the “kindling hypothesis,” which proposes that early mood episodes are typically triggered by major life stressors, but as the illness recurs, episodes begin to emerge with less and less provocation, as if the brain becomes sensitized to cycling on its own.14PubMed Central. Kindling of life stress in bipolar disorder: comparison of sensitization and autonomy models Brain imaging after a first manic episode supports this view. Patients who went on to have another mood episode showed measurable gray matter volume changes that were not found in those who stayed in remission, suggesting that preventing recurrence might slow or halt the brain’s structural decline.15PubMed. Neuroprogression and episode recurrence in bipolar I disorder This is one of the stronger arguments for early, aggressive treatment: each episode is not just a period of suffering but a potential source of lasting biological damage.
A Dysregulated Stress Hormone System
The body’s main stress response system, the hypothalamic-pituitary-adrenal (HPA) axis, is consistently abnormal in bipolar disorder. A meta-analysis found that people with bipolar disorder have elevated baseline cortisol levels as well as elevated levels of ACTH, the hormone that tells the adrenal glands to produce cortisol.16PubMed. The HPA axis in bipolar disorder: Systematic review and meta-analysis Even patients in remission show an exaggerated cortisol response when their HPA axis is challenged with a standardized test, suggesting the dysregulation persists between mood episodes rather than being merely a symptom of them.17The British Journal of Psychiatry. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
This chronic excess of cortisol is not harmless. Persistently high cortisol levels can damage neurons, and this has been proposed as a mechanism behind the cognitive difficulties many patients experience even when their mood is stable. Manic episodes in particular may be preceded by rising ACTH and cortisol, suggesting the stress system may be involved in triggering mood episodes rather than just responding to them.18PubMed. Hypothalamic-pituitary-adrenal axis and bipolar disorder
Inflammation, the Blood-Brain Barrier, and Immune Activation
Bipolar disorder was once considered a purely neurological or psychological problem, but there is now strong evidence that the immune system plays a role. Postmortem brain studies have found increased levels of inflammatory signaling molecules called cytokines in the central nervous system, consistent with elevated circulating cytokine levels measured in living patients during mood episodes.19PubMed Central. Cytokines in bipolar disorder: paving the way for neuroprogression
The blood-brain barrier, which normally restricts what can pass from the bloodstream into the brain, appears to be compromised in bipolar disorder. Studies have found elevated blood levels of cell adhesion molecules called ICAM and VCAM, which the cells lining the blood-brain barrier produce in greater quantities when they are inflamed. Multiple studies have reported that ICAM levels are increased in people with bipolar disorder regardless of their current mood state, with even higher levels during mania. Patients with a longer illness duration had higher ICAM levels than those more recently diagnosed.20PubMed Central. Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications When the barrier becomes leaky, peripheral immune cells and inflammatory molecules that would normally be kept out can enter the brain and activate further inflammation, creating a feedback loop that may worsen the disease over time.
Cellular Energy Problems and Mitochondrial Dysfunction
Neurons are extraordinarily energy-hungry cells, and there is growing evidence that the cellular power plants known as mitochondria do not function normally in bipolar disorder. Multiple lines of research connect mitochondrial dysfunction to bipolar disorder through several pathways: disrupted energy metabolism, increased oxidative stress (a buildup of damaging molecules that cells normally neutralize), dysregulated calcium handling inside cells, and increased cell death.21ScienceDirect / IBRO Neuroscience Reports. Mitochondria dysfunction and bipolar disorder: From pathology to therapy The calcium signaling connection here circles back to the CACNA1C genetic finding: if both the channels that let calcium into neurons and the mitochondria that depend on calcium homeostasis are compromised, the cell’s ability to function and survive is doubly threatened.
Related to cellular energy, the purinergic system has attracted attention. Purines are molecules involved in energy transfer and neurotransmission. Uric acid, the end product of purine breakdown, has been found to be elevated during first manic episodes in patients who had never taken psychiatric medication, suggesting increased purine turnover during mania.22PubMed Central. Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode Purines regulate mood, sleep, activity, appetite, and cognitive function, and uric acid levels may track with energy and activity levels more broadly.23PubMed Central. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
Circadian Rhythms and Clock Genes
Sleep disruption is one of the most reliable warning signs of an impending mood episode, and it turns out that the link between bipolar disorder and the body’s internal clock runs deep. Research on disturbed sleep-wake cycles, abnormal patterns of melatonin and cortisol secretion, and variations in clock genes all point to a fundamental relationship between bipolar disorder and circadian rhythm.24PubMed Central. Bipolar Disorder, Circadian Rhythm and Clock Genes This is not simply a matter of poor sleep habits. The molecular machinery that drives circadian rhythms overlaps with several of the pathways already described. An overactive enzyme called GSK3, which has been implicated in bipolar disorder through multiple research approaches, directly regulates circadian clock proteins. Its overactivity has downstream consequences including increased inflammation, greater oxidative stress, and disrupted circadian regulation, all of which feed back into the disorder’s core biology.25PubMed Central. Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications
Neurotrophic Support and Brain Maintenance
BDNF, or brain-derived neurotrophic factor, is a protein that supports the survival and growth of neurons. It acts as a kind of maintenance signal, helping the brain adapt and repair. People with bipolar disorder tend to have lower serum levels of BDNF compared to healthy individuals, along with higher levels of GSK3β, the enzyme that when overactive can suppress neurotrophic support and promote cell death.26PubMed Central. Clinical Significance and Changes in Levels of Serum BDNF, mBDNF, AQP4, proBDNF, and GSK3β in Individuals Diagnosed With Bipolar Disorder Reduced BDNF may help explain why repeated mood episodes are associated with progressive cortical thinning: each episode may overwhelm the brain’s ability to repair and maintain its own neurons.
Epigenetics and How Environment Gets Under the Skin
Genes set the stage for bipolar vulnerability, but the environment helps decide whether that vulnerability becomes an illness. One mechanism for this is epigenetics, where chemical modifications to DNA change how actively genes are read without altering the genetic code itself. Childhood trauma has emerged as a particularly important environmental factor. In patients with bipolar disorder, childhood emotional abuse was associated with altered methylation patterns on the FKBP5 gene, which regulates the stress response, and this effect depended on which genetic variant a person carried.27PubMed. Effect of interaction between a specific subtype of child abuse and the FKBP5 rs1360780 SNP on DNA methylation among patients with bipolar disorder Other research found altered methylation at the DDR1 gene in patients with bipolar disorder compared to healthy controls, with childhood trauma acting as an independent risk factor for suicidal behavior among those patients.28Molecular Psychiatry. Associations of altered leukocyte DDR1 promoter methylation and childhood trauma with bipolar disorder and suicidal behavior in euthymic patients
Interestingly, the epigenetic response to adversity is not always the same in people with the disorder as in those without it. One study found that childhood adversity was linked to increased methylation of the KITLG gene in healthy individuals but not in people with bipolar disorder, suggesting that the epigenetic landscape is already different in the illness and may not respond to environmental inputs in the usual way.29Frontiers in Psychiatry. Childhood Adversity Is Associated With Increased KITLG Methylation in Healthy Individuals but Not in Bipolar Disorder Patients
What Medications Reveal About the Disease
Sometimes you learn the most about what is wrong by studying what fixes it. Lithium, the oldest and still one of the most effective mood stabilizers, acts on at least two major signaling pathways. It depletes intracellular inositol, disrupting a signaling cascade that overactive neurons rely on, and it inhibits GSK3, the enzyme whose overactivity has been linked to inflammation, oxidative stress, circadian disruption, and reduced neurotrophic support.30PubMed. Search for a common mechanism of mood stabilizers Valproic acid, another cornerstone mood stabilizer, hits both of these same targets, and researchers have proposed that inositol depletion and GSK3 inhibition may be inter-related parts of a unified mechanism.31PubMed Central. Inositol depletion, GSK3 inhibition and bipolar disorder More recent work has continued to solidify GSK3β inhibition as central to lithium’s benefits, with downstream neuroprotective and anti-oxidative effects that likely account for its ability to prevent the brain changes associated with recurrent episodes.32PubMed. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding
Do Bipolar I and Bipolar II Have Different Biology?
Given that bipolar I (with full manic episodes) and bipolar II (with less severe hypomanic episodes) have distinct clinical profiles, it is reasonable to ask whether their underlying biology differs as well. The answer, somewhat frustratingly, is that we do not yet have a clear picture. Both subtypes show gray matter reductions in ventromedial prefrontal regions compared to healthy people. But bipolar I is associated with far more widespread gray matter loss across frontal, temporal, parietal, and parahippocampal areas, while bipolar II patients do not show these broader reductions at standard detection thresholds.33PubMed. Regional brain gray matter abnormalities in patients with bipolar II disorder A review of imaging and metabolic studies comparing the two subtypes found surprisingly few direct comparisons, and among those that existed, differences were sparse and inconsistent.34PubMed. Neurobiological findings in bipolar II disorder compared with findings in bipolar I disorder Whether the two subtypes represent different degrees of the same process or genuinely different biological entities remains an open question.
The Gut and the Brain
One of the newer frontiers in bipolar research is the gut-brain axis. The trillions of microorganisms living in the digestive tract communicate with the brain through immune, hormonal, and neural pathways, and emerging evidence shows that the composition of gut bacteria is altered in people with bipolar disorder. Gut microbial imbalances have been linked not only to mood symptoms but also to the cognitive impairment that many patients experience between episodes.35PubMed Central. Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence The research here is still early, and it is not yet clear whether gut changes are a cause, a consequence, or both. But the connection to inflammation, immune activation, and metabolic function makes the gut a plausible contributor to the broader pathophysiology rather than just a bystander.
An Evolutionary Lens
If bipolar disorder has such strong genetic underpinnings and is so disabling, why has natural selection not weeded it out? One hypothesis proposes that the traits underlying bipolar disorder evolved as adaptations to severe seasonal climates during the Pleistocene. In this framework, the ability to shift between a high-energy, low-sleep state during short productive summers and a low-energy, conserving state during harsh winters could have been advantageous for survival in extreme northern environments.36PubMed. Evolutionary origin of bipolar disorder-revised: EOBD-R This remains speculative, but it offers a way to think about why the genetic architecture persists: the individual variants that contribute to bipolar risk may each confer some adaptive benefit, and it is only their particular combination, in a particular environment, that tips into disorder. The circadian and seasonal rhythm disruptions that characterize the illness fit neatly into this framework, as would the involvement of clock genes and the HPA axis in driving mood cycles.